Financial Year |
March 31 2023 |
Monetary Funds |
32,067,291,940.81 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
141,837,434.18 |
Advances to Suppliers |
513,978,757.28 |
Other Receivables |
960,495,264.05 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
1,500,000.00 |
Inventories |
26,138,864,881.84 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
891,113,170.14 |
Total Current Assets |
60,713,581,448.30 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,983,355,911.83 |
Investment Properties |
1,231,128,451.37 |
Fixed Assetes |
5,377,256,765.23 |
Under-construction Projects |
2,167,370,849.32 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,447,193,796.00 |
R&D expenses |
1,858,301.89 |
Goodwill |
822,460,130.18 |
Long-Term Deferred and Prepaid Expenses |
1,119,777,927.75 |
Deferred Income Tax Assets |
1,070,226,473.61 |
Other Non-Current Assets |
568,021,572.65 |
Sub-Total of Non-Current Assets |
19,150,426,975.04 |
Total Assets |
79,864,008,423.34 |
Short-Term Loans |
1,929,681,030.80 |
Trading Financial liabilities |
-- |
Notes Payable |
1,553,226.29 |
Accounts Payable |
8,440,926,529.24 |
Accounts Received In Advance |
6,977,008.91 |
Employee Compensation Payable |
513,092,895.92 |
Taxes Payable |
3,666,141,059.26 |
Interest Payable |
-- |
Dividend Payable |
2,098,825.30 |
Other payables |
2,172,560,146.70 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
727,258,221.61 |
Other Current Liabilities |
15,443,219.12 |
Sub-Total of Current Liabilities |
18,931,489,834.21 |
Long-term Loans |
2,593,553,732.32 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
47,205,601.47 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
4,649,398,318.32 |
Total Liabilities |
23,580,888,152.53 |
Paid-In Capital(Or Share Stock) |
2,068,859,044.00 |
Capital Surplus |
17,486,404,857.73 |
Surplus Reserve |
1,050,985,921.87 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
29,749,267,352.53 |
Minority Stockholder's Interest |
5,713,030,140.33 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
50,570,090,130.48 |
Owner's Equity(Stockholder's Equity) |
56,283,120,270.81 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
79,864,008,423.34 |